Real-World Evidence Can Play Important Role In OTC Regulation – AESGP Study
A published article from AESGP argues for the increased acceptability, application and use of real-world evidence in the OTC sector where it “may present a more intuitive or efficient way of generating data” compared to randomized controlled trials.
You may also be interested in...
GSK revealed price increases in the US, Europe and China as it posted Q3 sales up high single-digits, with gains in key categories such as pain relief and vitamins, minerals and supplements.
A sharp improvement in cold and flu sales trends in the third quarter has prompted Reckitt to increase its sales guidance for the full year. However, the UK-based firm is warning that these trends remain unpredictable for the remainder of 2021.
Boiron has gained the rights to distribute Bionorica's Canephron herbal medicine in France as it continues to diversify its portfolio away from homeopathy.